TORRANCE, Calif., May 29, 2012 /PRNewswire/ -- Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc.,

Praises Senate for Addressing Needs of Rare Disease Patients WASHINGTON, May 24, 2012 /PRNewswire-USNewswire/ -- The National Organization for Rare Disorders (NORD) applauds

WASHINGTON, May 15, 2012 /PRNewswire-USNewswire/ -- The House and Senate versions of "PDUFA V" are on track for timely congressional approval and represent the most significant legislative advances

Aeterna Zentaris to continue ongoing Phase 3 trial in multiple myeloma QUEBEC CITY, May 7, 2012 /PRNewswire/ - Aeterna Zentaris Inc.

SAN DIEGO, April 9, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced the establishment of a Regulatory Advisory Board (RAB).